147 related articles for article (PubMed ID: 9191904)
1. The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors.
Little MP; Charles MW
Int J Radiat Biol; 1997 May; 71(5):589-602. PubMed ID: 9191904
[TBL] [Abstract][Full Text] [Related]
2. Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors.
Little MP
Int J Radiat Biol; 1997 Dec; 72(6):715-26. PubMed ID: 9416794
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
Little MP
Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk estimates from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy.
Schneider U; Walsh L
Radiat Environ Biophys; 2008 Apr; 47(2):253-63. PubMed ID: 18157543
[TBL] [Abstract][Full Text] [Related]
5. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
6. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
7. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
8. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
9. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
10. Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 1996 Jul; 70(1):83-94. PubMed ID: 8691040
[TBL] [Abstract][Full Text] [Related]
11. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
[TBL] [Abstract][Full Text] [Related]
12. The proportion of thyroid cancers in the Japanese atomic bomb survivors associated with natural background radiation.
Little MP
J Radiol Prot; 2002 Sep; 22(3):279-91. PubMed ID: 12375789
[TBL] [Abstract][Full Text] [Related]
13. Curvilinearity in the dose-response curve for cancer in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1505-9. PubMed ID: 9467073
[TBL] [Abstract][Full Text] [Related]
14. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
15. Radiation-related cancer risks at low doses among atomic bomb survivors.
Pierce DA; Preston DL
Radiat Res; 2000 Aug; 154(2):178-86. PubMed ID: 10931690
[TBL] [Abstract][Full Text] [Related]
16. Corrections in the atomic bomb data to examine low dose risk.
Baker GS; Hoel DG
Health Phys; 2003 Dec; 85(6):709-20. PubMed ID: 14626322
[TBL] [Abstract][Full Text] [Related]
17. Skin cancer incidence among atomic bomb survivors from 1958 to 1996.
Sugiyama H; Misumi M; Kishikawa M; Iseki M; Yonehara S; Hayashi T; Soda M; Tokuoka S; Shimizu Y; Sakata R; Grant EJ; Kasagi F; Mabuchi K; Suyama A; Ozasa K
Radiat Res; 2014 May; 181(5):531-9. PubMed ID: 24754560
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
Little MP
Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
[TBL] [Abstract][Full Text] [Related]
19. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
20. Describing time and age variations in the risk of radiation-induced solid tumour incidence in the Japanese atomic bomb survivors using generalized relative and absolute risk models.
Little MP; Muirhead CR; Charles MW
Stat Med; 1999 Jan; 18(1):17-33. PubMed ID: 9990690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]